What to expect
The procedure
A needle is passed through the back into a worn lumbar disc, or into the small joints at the back of the spine. Most people who describe it were sedated or under a general anaesthetic.[5] If your own cells are used they are taken from the back of the hip bone first, and patients describe that harvest as much easier than the spinal injection.[5]
How many sessions
Every controlled trial used a single injection.[1][6][2] Patients often describe many sites treated in one sitting, sometimes 17 to more than 50 injections across discs, joints and ligaments.[5] Ask why each one is needed.
Recovery
Trial protocols restricted strenuous activity for two weeks and anti-inflammatory painkillers for six.[4] Two in three patients who described the first weeks had a flare worse than their usual pain, mostly settling within one to three weeks, sometimes lasting two to three months.[5]
When it works, and how long it lasts
Patients rarely report relief before six weeks, and most name three to six months.[5] In the blinded trials, which followed people for one to three years, the cell groups never pulled clearly ahead of the dummy groups.[1][2][4]
Who it suits, and who it doesn't
The largest trial enrolled people with one painful disc. It excluded severe degeneration, more than one painful disc, a trapped nerve, previous surgery on that disc, osteoporosis and a body mass index over 40.[7] A higher body weight predicted failure in another trial.[4]
Risks
More back pain for a few days is common, and almost as common after a saltwater injection.[7] The serious risk is infection of the disc: two serious events among 136 published patients.[8] Puncturing a disc also carries its own risk: over ten years, discs punctured once wore faster and herniated more often than untouched discs.[9]
In blinded trials, cells did no better than a dummy injection
Does it work? People often improve after the procedure, but people given a dummy injection improve almost as much. Four blinded trials have now tested it, and none found a meaningful difference.
Where it is allowed
United States. The FDA says no regenerative medicine therapy is approved for any orthopaedic condition, and names back pain and disc disease.[10]
Malaysia. Donor and lab-grown cells must be registered with the Drug Control Authority before a clinic can use them.[11]
Mexico. COFEPRIS has said stem cell treatments lack authorisation.[12]
Is PRP better?
No trial has compared them directly. Pooled figures favour PRP slightly at six months, but the best-controlled PRP disc trial was negative at a year.[14][15] PRP vs stem cells
Common questions
Will it fix a herniated or bulging disc?
No blinded trial has shown a change on the scan that went with a real benefit.[1][2][3] Of patients who had a scan before and after, most found nothing had changed, even when they felt better.[5]
What about the facet joints?
No randomised trial of cells in the facet joints has been published. The randomised facet trials tested PRP.[13]
Questions to ask a clinic
- What cell type is it, and how many cells go into each disc?
- Does it go into the disc itself, or around it?
- Will the needle be guided by X-ray or another scan?
- Which of my diagnoses can this treat, and which can it not?
- How many sites will you inject, and why each one?
- What do you do to prevent a disc infection?
- What can I not do afterwards, and for how long?
Sources
17 references
- Beall DP, et al. Efficacy and safety of allogeneic mesenchymal precursor cells with and without hyaluronic acid for treatment of chronic low back pain: a prospective, randomized, double blind, concurrent-controlled 36-month study. The Spine Journal, 2025. Link
- Pers YM, et al. Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study). Annals of the Rheumatic Diseases, 2024. Link
- Vadalà G, et al. Intradiscal Mesenchymal Stromal Cell Therapy for the Treatment of Low Back Pain Due to Moderate-to-Advanced Multilevel Disc Degeneration: A Preliminary Report of a Double-Blind, Phase IIB Randomized Clinical Trial (DREAM Study). JOR spine, 2025. Link
- Levi D, et al. Bone marrow concentrate intradiscal injection for chronic discogenic low back pain: A double-blind randomized sham-controlled trial. Interventional Pain Medicine, 2025. Link
- StemFinder review of first-hand patient accounts on Reddit and patient forums, 2026. Method
- Amirdelfan K, et al. Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: a prospective randomized, placebo-controlled 36-month study of safety and efficacy. The Spine Journal, 2021. Link
- Mesoblast, Ltd. A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Alone or Combined With Hyaluronic Acid (HA) in Subjects With Chronic Low Back Pain (MSB-DR003). ClinicalTrials.gov, US National Library of Medicine, 2026. Link
- Jerome MA, et al. Risks of Intradiscal Orthobiologic Injections: A Review of the Literature and Case Series Presentation. International Journal of Spine Surgery, 2021. Link
- Carragee EJ, et al. 2009 ISSLS Prize Winner: Does discography cause accelerated progression of degeneration changes in the lumbar disc: a ten-year matched cohort study. Spine, 2009. Link
- U.S. Food and Drug Administration. Important Patient and Consumer Information About Regenerative Medicine Therapies. 2024. Link
- National Pharmaceutical Regulatory Agency, Ministry of Health Malaysia. Guidance Document and Guidelines for Registration of Cell and Gene Therapy Products (CGTPs) in Malaysia, Second Edition (September 2025). National Pharmaceutical Regulatory Agency (NPRA), Malaysia, 2025. Link
- Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS). La COFEPRIS suspendió clínica del D.F. que ofrecía tratamientos con Células Madre sin aval científico. COFEPRIS, Secretaría de Salud, Mexico, 2015. Link
- Manchikanti L, et al. A Systematic Review of Regenerative Medicine Therapies for Axial Spine Pain of Facet Joint Origin. Current Pain and Headache Reports, 2025. Link
- Salamanna F, et al. Platelet-Rich Plasma vs. Mesenchymal Stem Cells for Lumbar Disc Degeneration: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 2026. Link
- Schepers MO, et al. Effectiveness of intradiscal platelet rich plasma for discogenic low back pain without Modic changes: A randomized controlled trial. Interventional Pain Medicine, 2022. Link
- Manchikanti L, et al. Comprehensive Evidence-Based Guidelines for Regenerative Therapies in the Management of Chronic Low Back Pain: 2025 Update from the American Society Of Interventional Pain Physicians (ASIPP). Pain Physician, 2025. Link
- American Academy of Orthopaedic Surgeons. Orthobiologics (Regenerative Medicine) FAQ. OrthoInfo, American Academy of Orthopaedic Surgeons, 2026. Link



